Genes with aberrant expression in murine preneoplastic intestine show epigenetic and expression changes in normal mucosa of colon cancer patients

Cancer Prevention Research

Volumn 6, Issue 11, 2013, Pages 1171-1181

  Leclerc, Daniel ^a   Lévesque, Nancy ^a   Cao, Yuanhang ^a   Deng, Liyuan ^a   Wu, Qing ^a   Powell, Jasmine ^b   Sapienza, Carmen ^b   Rozen, Rima ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; FOLIC ACID; NR1H4 PROTEIN; PROTEIN; PYCARD PROTEIN; PYRUVATE DEHYDROGENASE KINASE 4; RETINOIC ACID; SPRR1A PROTEIN; SPRR2A PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DIET; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE TUMOR; LIPID METABOLISM; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ORTHOLOGY; POLYP; PRIORITY JOURNAL; PYROSEQUENCING; UPREGULATION;

ANIMALS; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; INTESTINAL NEOPLASMS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84887929046     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0198     Document Type: Article

References (48)

1. Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007;16:2533-47. (Pubitemid 351196307)
2. Goel A, Boland CR. Epigenetics of colorectal cancer. Gastroenterology 2012;143:1442-60.
3. Al-Sohaily S, Biankin A, Leong R, Kohonen-Corish M, Warusavitarne J. Molecular pathways in colorectal cancer. J Gastroenterol Hepatol 2012;27:1423-31.
4. Li X, Yao X, Wang Y, Hu F, Wang F, Jiang L, et al. MLH1 Promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features. PLoS ONE 2013;8:e59064.
5. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005;97:1330-8. (Pubitemid 41487800)
6. Milicic A, Harrison LA, Goodlad RA, Hardy RG, Nicholson AM, Presz M, et al. Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo. Cancer Res 2008;68:7760-8.
7. Silviera ML, Smith BP, Powell J, Sapienza C. Epigenetic differences in normal colon mucosa of cancer patients suggest altered dietary metabolic pathways. Cancer Prev Res 2012;5:374-84.
8. Knock E, Deng L, Wu Q, Leclerc D, Wang XL, Rozen R. Low dietary folate initiates Intestinal Tumors in Mice, with altered expression of G2-M Checkpoint Regulators Polo-Like Kinase 1 and cell division cycle 25c. Cancer Res 2006;66:10349-56. (Pubitemid 44799754)
9. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997;57:1098-102. (Pubitemid 27138608)
10. Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM. Colorectal cancer and the methylenetetrahydrofolate reductase 677C → T and methionine synthase 2756A → G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004;13:2175-80. (Pubitemid 40054314)
11. Teng Z, Wang L, Cai S, Yu P, Wang J, Gong J. The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies. PLoS ONE 2013;8:e55332.
12. Knock E, Deng L, Wu Q, Lawrance AK, Wang XL, Rozen R. Strain differences in mice highlight the role of DNA damage in Neoplasia induced by low dietary folate. J Nutr 2008;138:653-8. (Pubitemid 351469405)
13. Garcia-Crespo D, Knock E, Jabado N, Rozen R. Intestinal neoplasia induced by low dietary folate is associated with altered tumor expression profiles and decreased apoptosis in mouse normal intestine. J Nutr 2009;139:488-94.
14. Knock E, Deng L, Krupenko N, Mohan RD, Wu Q, Leclerc D, et al. Susceptibility to intestinal tumorigenesis in folate-deficient mice may be influenced by variation in one-carbon metabolism and DNA repair. J Nutr Biochem 2011;11:1022-9.
15. Leclerc D, Cao Y, Deng L, Mikael LG, Wu Q, Rozen R. Differential gene expression and methylation in the retinoid/PPARA pathway and of tumor suppressors may modify intestinal tumorigenesis induced by low folate in mice. Mol Nutr Food Res 2013;57:686-97.
16. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 2013;41:D991-5.
17. Bottone FG Jr, Moon Y, Kim JS, Alston-Mills B, Ishibashi M, Eling TE. The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3). Mol Cancer Ther 2005;5:693-703. (Pubitemid 40767113)
18. Huang Y, Zhao Q, Chen GQ. Phospholipid scramblase 1. Sheng Li Xue Bao 2006;58:501-10.
19. Chen W, Possemato R, Campbell KT, Plattner CA, Pallas DC, Hahn WC. Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 2004;5:127-36. (Pubitemid 38283799)
20. Puustinen P, Junttila MR, Vanhatupa S, Sablina AA, Hector ME, Teittinen K, et al. PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma. Cancer Res 2009;69:2870-7.
21. Westermarck J, Hahn WC. Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol Med 2008;14:152-60.
22. Takeshita F, Ishii KJ. Intracellular DNA sensors in immunity. Curr Opin Immunol 2008;20:383-8.
23. Rizzatti EG, Falcão RP, Panepucci RA, Proto-Siqueira R, Anselmo-Lima WT, Okamoto OK, et al. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. Br J Haematol 2005;130:516-26.
24. García-Escudero R, Paramio JM. Gene expression profiling as a tool for basic analysis and clinical application of human cancer. Mol Carcinog 2008;47:573-9.
25. Porté S, Xavier Ruiz F, Giménez J, Molist I, Alvarez S, Domínguez M, et al. Aldo-keto reductases in retinoid metabolism: search for substrate specificity and inhibitor selectivity. Chem Biol Interact 2013;202:186-94.
26. Jeong JY, Jeoung NH, Park KG, Lee IK. Transcriptional regulation of pyruvate dehydrogenase kinase. Diabetes Metab J 2012;36:328-35.
27. Goto T, Kim YI, Funakoshi K, Teraminami A, Uemura T, Hirai S, et al. Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways. Am J Physiol Endocrinol Metab 2011;301:E1022-32.
28. Riojas MA, Guo M, Glöckner SC, Machida EO, Baylin SB, Ahuja N. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer. Cancer Biol Ther 2007;6:1710-6. (Pubitemid 351590305)
29. Friso S, Udali S, Guarini P, Pellegrini C, Pattini P, Moruzzi S, et al. Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk. Cancer Epidemiol Biomarkers Prev 2013;22:348-55.
30. Sung MK, Yeon JY, Park SY, Park JH, Choi MS. Obesity-induced metabolic stresses in breast and colon cancer. Ann N Y Acad Sci 2011;1229:61-8.
31. Menendez JA, Joven J, Cufí S, Corominas-Faja B, Oliveras-Ferraros C, Cuyàs E, et al. The Warburg effect 2.0: metabolic reprogramming of cancer stem cells. Cell Cycle 2013;12:1166-79.
32. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 2001;3:181-93. (Pubitemid 33741893)
33. D'Ambrosio DN, Clugston RD, Blaner WS. Vitamin A metabolism: an update. Nutrients 2011;3:63-103.
34. Pham DNT, Leclerc D, Lévesque N, Deng L, Rozen R. β-Carotene 15,15′-monooxygenase 1 and its substrate β-carotene modulate migration and invasion in colorectal carcinoma cells. Am J Clin Nutr 2013;98:413-22.
35. Bottiglieri T, Arning E, Wasek B, Nunbhakdi-Craig V, Sontag JM, Sontag E. Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain. J Neurosci 2012;32:9173-81.
36. Wallace K, Grau MV, Levine AJ, Shen L, Hamdan R, Chen X, et al. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res 2010;3:1552-64.
37. Hahn MA, Wu X, Li AX, Hahn T, Pfeifer GP. Relationship between gene body DNA methylation and intragenic H3K9me3 and H3K36me3 chromatin marks. PLoS ONE 2011;19:e18844.
38. Jjingo D, Conley AB, Yi SV, Lunyak VV, Jordan IK. On the presence and role of human gene body DNA methylation. Oncotarget 2012;3:462-74.
39. Pipaon C, Real PJ, Fernandez-Luna JL. Defective binding of transcriptional repressor ZEB via DNA methylation contributes to increased constitutive levels of p73 in Fanconi anemia cells. FEBS Lett 2005;579:4610-4. (Pubitemid 41218635)
40. Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB, et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 2010;207:1045-56.
41. Wen H, Ting JP, O'Neill LA. A role for the NLRP3 inflammasome in metabolic diseases-did Warburg miss inflammation? Nat Immunol 2012;13:352-7.
42. Hong SH, Lee JE, Jeong JJ, Hwang SJ, Bae SN, Choi JY, et al. Small proline-rich protein 2 family is a cluster of genes induced by estrogenic compounds through nuclear estrogen receptors in the mouse uterus. Reprod Toxicol 2010;30:469-76.
43. Song H, Zhang B, Watson MA, Humphrey PA, Lim H, Milbrandt J. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene 2009;28:3307-19.
44. Yamashita S, Tsujino Y, Moriguchi K, Tatematsu M, Ushijima T. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci 2006;97:64-71. (Pubitemid 43257029)
45. Fujiwara S, Kawano Y, Yuki H, Okuno Y, Nosaka K, Mitsuya H, et al. PDK1 inhibition is a novel therapeutic target in multiple myeloma. Br J Cancer 2013;108:170-8.
46. Mencarelli A, Cipriani S, Renga B, D'Amore C, Palladino G, Distrutti E, et al. FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity. Nutr Metab Cardiovasc Dis 2013;23:94-101.
47. Mikeska T, Bock C, El-Maarri O, Hübner A, Ehrentraut D, Schramm J, et al. Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. J Mol Diagn 2007;9:368-80.
48. Jain S, Wojdacz TK, Su YH. Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer. Expert Rev Mol Diagn 2013;13:283-94.